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“HbA1c, Weight, Quality of life and Hypoglycaemia awareness after a structured 
education programme teaching carbohydrate counting and insulin dose 
adjustment” 
 
Julie Ellis-Gowland 
Objective   The primary aim was to assess the effects of Aintree Hospital’s ‘4-Step’ 
programme which teaches carbohydrate counting and insulin dose adjustment to patients 
with Type 1 diabetes, on HbA1c, Weight, Quality of life and Hypoglycaemia awareness.  
A secondary aim was to compare the effects of group education and one to one clinics in 
HbA1c, Weight, Quality of life and Hypoglycaemia awareness. 
 
Methods All parameters were measured at baseline and four months later. HbA1c is 
measured by blood test, Quality of Life using the Problem Areas in Diabetes 
questionnaire and Hypoglycaemia Awareness using the ‘Symptom Awareness of 
Hypoglycaemia’ questionnaire.   
 
A convenience sampling technique was used whereby patient data was collected over a 6 
month period from all patients who fit the criteria. Those excluded were patients with 
patients receiving nutritional support and those undertaking weight management 
programmes, those undergoing chemo/radiotherapy and those on renal dialysis. Fifty two 
sets of patient data were collected in total. All patients underwent either group or one-to-
one clinic sessions.  The programme was of four weeks duration and patients were 
followed up for repeat measurements three months after the programme.  Where 
populations fit a normal ’Gaussian’ distribution parametric paired t-tests were chosen for 
statistical analysis. Where the population was found to be skewed, non- parametric 
Wilcoxon tests were used.  
 
Results Following the programme overall HbA1c levels improved by 0.29% 
(p=0.008) with greater improvements occurring in those undertaking joint clinics 
(p=0.037) than groups (p=0.111).  There was an overall weight loss of 0.5kg which did 
not reach statistical significance (p=0.100).  However weight loss was greater in those 
attending group education (p=0.04) compared to those attending clinics (p=0.438).  
Quality of life scores improved by 11% overall (p=0.000) with group education being 
slightly more effective in achieving improvements (p=0.000) than group education 
(p=0.001).  There was no change in symptoms of Hypoglycaemia awareness in the 
population as a whole (p=0.052) although as with HbA1c, those undergoing individual 
education had great improvements (p=0.046) compared to those in groups (p=0.409). 
 
Conclusions  The study has served to demonstrate the effectiveness of Aintree’s ‘4-
Step’ programme in achieving key improvements in clinical and non-clinical aspects of 
patients’ diabetes care. While the improvement in HbA1c is beneficial, it is unclear 
whether this is sustained over time.  Longer term follow-up and refresher education at 
intervals may increase the likelihood of sustained clinical benefits. Whilst weight loss 
was shown to be minimal, the study importantly demonstrates that the ‘4-Step’ 
programme does not lead to weight gain, an important finding when offering a 
programme enabling greater food freedom. Quality of Life improvements were highly 
significant with impressive improvements. However, future studies would benefit from 
including a more detailed analysis of the Quality of Life questionnaire. Whilst 
highlighting aspects which are most favourably influenced by the programme, this would 
also enable targeting of those aspects which demonstrate lower levels of satisfaction for 
future service provision.  Hypoglycaemia Awareness did not improve, possibly due to the 
short study duration. Future evaluations may be better placed to measure frequency of 
hypoglycaemia for a more accurate assessment of the impact of the ‘4-Step’ programme 
on hypoglycaemic events. 
I hereby declare that work contained herewith is original and is entirely my own work 
(unless indicated otherwise). It has not been previously submitted in support of a Degree, 
qualification or other course. 
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Introduction 
 
Introduction 
 
Diabetes self-management education is now widely recognised as a critical element of 
care for all people with diabetes and is considered necessary in order to improve patient 
outcomes.  The need for structured education in diabetes care was highlighted by the 
publication of NICE guidance in 2003 which recommended that ‘structured patient 
education is made available to all people with diabetes at the time of initial diagnosis and 
then as required on an on-going basis, based on a formal, regular assessment of need’.  
There is much evidence demonstrating that structured education among diabetes patients 
is effective in improving knowledge, blood glucose control, weight and psychological 
well-being (Department of Health & Diabetes UK, 2005).  The National Service 
Framework for Diabetes Standard 3 (Department of Health, 2003), ‘Empowering people 
with diabetes’ states that ‘structured education can improve knowledge, reduce blood 
glucose levels without increasing frequency of hypoglycaemia, reduce weight and 
improve psychological well-being’.    
 
Personal empowerment of patients is being seen as increasingly important in the 
treatment of diabetes.  In the White Paper entitled Our Healthier Nation: Choosing Health 
(Department of Health, 2004), emphasis was placed upon the importance of personal 
choice in achieving good health.  According to the National Service Framework for 
Diabetes: Delivery Strategy (Department of Health, 2003),  patient empowerment and a 
person-centred approach should be a key part of successful treatment, as there is much 
evidence to show that these improve both clinical outcomes and quality of life.  
Recommendations include the provision of support and structured education alongside 
medication and clinical care as required a main aim of which is to enable those with 
diabetes to self-manage their lifestyles and their diabetes.   
 
In response to changing guidance, many local education initiatives across health  
authorities were developed offering a range of diabetes education models to all patients 
newly diagnosed with Type 1 or Type 2 diabetes.  The face of diabetes care was changing 
and a systematic review published in Acta Diabetologia  in 2008 entitled ‘Analysis of the 
2004-2007 literature on therapeutic patients education in diabetes: results and trends’ 
which sought to  assess the effectiveness of  therapeutic patient education in diabetes over 
3 years concluded that ‘huge progress seems to have been achieved; health care teams in 
charge of the education of diabetics are increasingly trying to focus education on the 
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patient (patient centred education)’ and this approach had resulted in more positive 
outcomes (Albano et al, 2008).  This is in line with Bandura’s (1997) teaching that the  
self-efficacy of the individual increases when he or she is empowered and that patient 
empowerment should form the basis for all diabetes structured education programmes.  
 
Specific structured education programmes which teach carbohydrate counting and insulin 
dose adjustment have been gaining momentum in the international diabetes community 
for a number of years and it is also of note that the only specific programme 
recommended in the NICE guidance was one such programme, the Dose Adjustment for 
Normal Eating (DAFNE) programme which was outlined by NICE (2003) as being a 
suitable option for individuals with Type 1 diabetes, as ‘one means of enabling people to 
self-manage this condition’.  The programme is underpinned by the notion of patient 
empowerment and shared diabetes care and the evidence for improvements in these areas 
is strong.   
 
The DAFNE programme and many similar regional models, teaches people with Type 1 
diabetes how to correctly identify and count carbohydrates in the diet and 
correspondingly adjust their insulin dose to match the carbohydrate load eaten.  This is in 
contrast to the patient administering a pre-determined number of units of insulin at each 
meal time and then aiming adjust carbohydrate intake accordingly.  Although this 
approach remains appropriate for many patients, strict portion control is difficult to 
achieve for many, who aim to eat a ‘similar sized meal’ and take the prescribed insulin 
dose accordingly.  Dietary guidance for these patients generally aims to assist with 
portion control, with focus on carbohydrate load and distribution over the course of the 
day.  However due to the variability of food intake, glycaemic control can be challenging.  
The ability to offer carbohydrate counting and insulin dose adjustment has been made 
possible with the advancement of insulin therapies which enable the patient to more 
successfully match carbohydrate intake with insulin doses thereby mimicking 
physiological insulin production. Consequently, where insulin dose is calculated 
individually to match the amount of carbohydrate eaten it is shown than benefits can 
include improved glycaemic control without increased risk of severe hypoglycaemia and 
greatly improved quality of life and treatment satisfaction (DAFNE Study Group, 2002).    
 
The publication of the landmark DAFNE Trial in 2002, which demonstrated clinically 
and statistically significant improvements in glycaemic control without exacerbation of  
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hypoglycaemia, weight loss and improved quality of life, paved the way for the 
development of many other such structured education models including BERTIE 
(Broomfield’s Education Resources for Training in Insulin and Eating), (Everett et al,  
2003), a course developed by Bournemouth Diabetes and Endocrine Centre which has 
been rolled out nationally by way of  offering training courses and resources for centres 
wishing to develop their own programmes.  Aintree’s ‘4 Step’ is one of many 
programmes which are developed and run locally and evaluated for effectiveness.  
 
Aintree University Hospitals Diabetes Team based at Walton Hospital site is a consultant 
led multi-disciplinary team offering acute in-patient and out-patients diabetes care within 
the local community.  The team is composed of seven consultant endocrinologists, one 
diabetes nurse consultant (DNC), five diabetes specialist nurses (DSN), one diabetes 
nurse educator (DNE), four podiatrists and a diabetes specialist dietician.  The service 
offers diabetes care to all Type 1 Diabetes patients, complex Type 2 patients, young 
people aged 16-25 and gestational diabetes cases and in accordance with NICE guidance, 
structured education is offered to all patients newly diagnosed with Type 1 diabetes.  
Patients diagnosed with Type 2 diabetes are offered education in the community under 
the auspices of the PCT.    
 
In November, 2007 in response to the identified benefits of carbohydrate counting 
education being demonstrated in clinical audits, the diabetes team identified a need for a 
cost effective method of delivering advanced carbohydrate counting.  Staff undertook 
training with the BERTIE group and the DAFNE equivalent ‘4 Step’ programme was 
developed by the team’s specialist dietitian and specialist nurse which would be offered 
to all patients fulfilling the criteria with the aim of  improving patients’ quality of life and 
glycaemic control. Subsequently, with the revision of NICE Guidance on Insulin Pump 
Therapy in 2008, the team commenced an insulin pump therapy service which also 
required carbohydrate counting education as a pre-requisite for patients commencing 
insulin pump therapy.  The ‘4 Step’ programme is delivered at Walton Diabetes Centre 
both in a group education format and in a one to one joint clinic and is offered to patients 
undergoing insulin pump therapy and non-pump patients wishing for improved glycaemic 
control.  Both group and one to one sessions are run by the diabetes specialist nurse and 
the specialist dietician.  
 
Much published data exists demonstrating evaluation of regional and national DAFNE  
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and equivalent courses, which measure the effectiveness of and inform the quality of, 
these programmes. The evidence has consistently demonstrated improvements in clinical 
and psychosocial outcomes such as HbA1c, quality of life and awareness of 
hypoglycaemia.  Although improvements in weight are not clearly demonstrated, it is 
important to know that these programmes do not result in weight gain which is important 
in programmes offering greater food freedom.   The Diabetes UK Care Recommendation 
for education of people with diabetes (2003) recommends monitoring the effects of 
education programmes on HbA1c, BMI, quality of life and hypoglycaemia awareness by 
way of well-designed audit and service evaluation and it is these recommendations which 
form the basis of this service evaluation. 
 
Rationale and hypotheses 
Rationale 1: HbA1c is shown to improve following diabetes structured education 
teaching carbohydrate counting and insulin dose adjustment (DAFNE, 2002). 
Hypothesis 1: There is a significant improvement in HbA1c in patients undertaking the 
‘4-Step’ programme. 
 
Rationale 2: Weight is shown not to change significantly in patients following diabetes 
structured education teaching carbohydrate counting and insulin dose adjustment (Everett 
et al, 2008). 
Hypothesis 2: There is neither weight gain or weight loss in patients undertaking the ‘4-
Step’ programme.  
 
Rationale 3: Quality of life is shown to improve following diabetes structured 
education teaching carbohydrate counting and insulin dose adjustment (Everett et al, 
2008). 
Hypothesis 3: There is a significant improvement in quality of life in patients 
undertaking the ‘4-Step’ programme. 
 
Rationale 4: Hypoglycaemia awareness is shown to improve following diabetes 
structured education teaching carbohydrate counting and insulin dose adjustments 
(Samaan et al, 2006). 
Hypothesis 4: There is a significant improvement in hypoglycaemia awareness in 
patients undertaking the ‘4-Step’ programme.  
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Rationale 5:  Group structured education is more effective than individual clinic 
education for lifestyle interventions (Norris et al, 2002). 
Hypothesis 5:  HbA1c, weight, quality of life and hypoglycaemia awareness will 
improve more in group settings than in clinics.
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2 Literature Review                   
 
2.1 Background 
Diabetes Mellitus is a chronic, progressive disease that affects 1.3 million people in 
England and is thought to absorb an estimated 5 per cent of all NHS expenditure (DOH, 
2004). Patients with diabetes are at increased risk of micro vascular complications, such 
as retinopathy, nephropathy and neuropathy as well as macro vascular complications such 
as myocardial infarction and stroke, with cardiovascular disease in fact being the leading 
cause of death in this patient group (Diabetes Control and Complications Trial, 1993).  
The implications of diabetes in terms of patient wellbeing and health service resources 
are far reaching and therefore high quality, effective patient care is imperative.  Diabetes 
care has been evolving over a number of years as the scientific evidence base has 
changed, which along with improved medications and enhanced knowledge about 
methods of education and delivery of care, has resulted in the development of education 
programmes with the aim of improving patient outcomes.  As previously discussed, 
Aintree University Hospital’s ‘4 Step’ programme was developed to teach carbohydrate 
counting and insulin dose adjustment with the aim of improving clinical and 
psychological outcomes.  In accordance with recommendations,  this project seeks to 
evaluate the impact of the ‘4 Step’ programme on glycaemic control, weight, 
hypoglycaemia awareness and quality of life in all patients undertaking the programme. 
 
2.2 General developments in diabetes structured education  
On the basis of much emerging evidence, the National Service Framework for Diabetes 
Standard 3 (Department of Health, 2003), ‘Empowering people with diabetes’ was 
published signifying a change of direction for health care professionals (HCP’s) in 
diabetes care, emphasising the use of structured education and diabetes self-management 
programmes, stating that  ‘structured education can improve knowledge, reduce blood 
glucose levels without increasing frequency of hypoglycaemia or weight and improve 
psychological well-being’.  There followed a rise in diabetes education models which 
were designed to enable patient autonomy, self-management and shared care.  A 
systematic review published in Acta Diabetologia  in 2008 entitled ‘Analysis of the 2004-
2007 literature on therapeutic patient education in diabetes: results and trends’ sought to  
assess the effectiveness of  therapeutic patient education in diabetes over a four year 
period.  Fifty four out of eighty studies demonstrated effectiveness of therapeutic patient 
education in terms of clinical, psychosocial and educational outcomes (Albano et al,  
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2008).  The authors concluded that ‘huge progress seems to have been achieved; health 
care teams in charge of the education of diabetics are increasingly trying to focus 
education on the patient (patient centred education)’.  The authors also observed that 
whereas past evaluation protocols focused solely upon bio clinical criteria, more recently 
they were seeing the inclusion of psychosocial and educational criteria which they 
describe as “a significant change with the evaluation of therapeutic education now being 
multifactorial” (Albano et al, 2008).  Patient education appeared to have switched from 
didactic presentations to interventions involving patient ‘empowerment’ with 
participation and collaboration (Norris et al, 2002).  Although it could be said that the 
review focused on just four years of publications therefore limiting the generalizability of 
the findings, it is sufficient to indicate changes have taken place in the field of therapeutic 
patient education.  This trend is seen nowhere more clearly than in the area of 
carbohydrate counting and insulin dose adjustment, otherwise known as intensive insulin 
therapy, with the establishment of numerous diabetes educational programmes both 
nationally and internationally.   These seek to embrace a holistic approach to diabetes 
care and emphasise quality of life outcomes as well bio-clinical outcomes through the 
vehicle of diabetes self-management education.   
 
2.3 The evolution of education providing carbohydrate counting and insulin dose 
adjustment  
Historically, people with Type 1 diabetes were expected to follow rigid meal plans with 
precisely controlled and often restricted carbohydrate portions to match the fixed twice 
daily insulin regimens (Petrak et al, 1992).  Patients would be given carbohydrate 
exchange lists of 10g items which they would aim to match to their insulin doses and 
naturally this would result in patients either restricting their carbohydrate intake or having 
to eat more than they otherwise would, which could have deleterious effects on health 
and weight.  Furthermore, accurate insulin dose adjustments were hard to achieve 
because of inaccurate blood glucose testing systems and the unpredictable nature of 
available insulins.  With the previously discussed increasing trend to recognize the 
importance of patient choice and quality of life, this approach has lost favour in recent 
years.  Rather than eating fixed amounts of carbohydrate, patients on set daily doses of 
insulin are now educated to identify carbohydrates and focus on the load (amount) and 
distribution (spread throughout the day) rather than calculated portions.  Education 
usually comprises teaching patients how to develop balanced meals and snacks with 
appropriate amounts of ‘healthier’ carbohydrate choices.  The aim is for consistency in  
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reduces the risk of developing retinopathy, neuropathy, nephropathy and cardiovascular 
disease (Delahanty et al, 1993).  Diabetes care should also involve aiming to maintain a 
healthy body weight and optimal quality of life.  
The importance of glycaemic control in diabetes has been well established.  Two 
landmark clinical trials have changed the face of diabetes care in recent years, providing 
best quality evidence for the benefits of glycaemic control.  The first was the Diabetes 
Control and Complications Trial, (DCCT), a randomised, controlled clinical trial which  
studied 1,441 volunteers with Type 1 diabetes at 29 medical centres in the US and 
Canada over a 10 year period between 1983 and 1993.   The DCCT examined whether 
intensive treatment (aiming for tighter glucose control by way of multiple daily injections 
(MDI) of insulin), as opposed to traditional twice daily injections, could decrease the 
frequency and severity of complications.  The results clearly demonstrated benefits of 
tight control in terms of micro vascular complications such as retinopathy, nephropathy 
and neuropathy.  At 6 year follow up, tight blood glucose control (4-10 mmols) was 
found to reduce the onset of retinopathy by 76% in those without pre-existing primary 
retinopathy.  In those with pre-existing mild to moderate retinopathy, progression was 
reduced by 54% (DCCT Research Group, 1993).  The benefits of intensive therapy were 
significant after three years and the magnitude of risk reduction increased over time.  
Similarly, tight control resulted in a significant reduction in the development of 
nephropathy, demonstrated by a 34% (p=0.004) reduction in micro albuminuria in those 
with pre-existing nephropathy and a 56% reduction in those without.  Micro albuminuria 
is the leaking of albumin into the urine indicating some degree of renal impairment and 
improved urinary albumin excretion is a positive outcome in terms of renal function.   In 
patients with no pre-existing neuropathy, tight glycaemic control was found to reduce its 
onset by 69% (p=0.006) compared to conventional therapy.   
However, intensifying insulin therapy to achieve tight glycaemic control was not found to 
be without problems as episodes of severe hypoglycaemia increased (p<0.001).  
Furthermore, intensive treatment was associated with a 33% increase in weight gain.  
Although much useful evidence was reported, the study fell short of identifying a suitable 
threshold for HbA1c (glycosylated haemoglobin), the gold standard blood glucose 
measure for diabetes.  Recommendations were made for maintenance of blood glucose 
levels as close to the normal range as possible without increasing risk of hypoglycaemia.  
Administering multiple daily injections does incur an additional burden to the patient and 
prior to the DCCT there was no medical proof of any benefits to MDI compared with 
conventional therapy of twice daily insulin.  Although the DCCT studied only a restricted 
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group of Type 1 diabetes patients, many clinicians began recommending tight control to 
patients with both Type 1 and Type 2 diabetes.  HbA1c measures degree of glycosylated 
haemoglobin out of 100% over an 8 to 12 week period and is therefore a useful measure 
of blood coagulation and overall diabetes control.  Even very small changes in HbA1c are 
considered clinically significant with their effects upon outcomes firmly established.   
The (UKPDS) United Kingdom Prospective Diabetes Study was a large multi-centre, 
prospective, randomised controlled intervention trial which assessed 5100 patients newly  
diagnosed with Type 2 diabetes over a 20 year period to 1999 to assess the impact of 
tighter glycaemic control on future risk factors.  Patients were recruited and initially 
treated with diet. The 95% who remained hyperglycaemic (fasting glucose >6mmols/L) 
were randomly allocated to different therapies to determine outcomes.  These included 
continuation of diet only, inclusion of an oral hypoglycaemic agent (OHA) such as 
Gliclazide (an insulin stimulating drug), or injected insulin or both (Stratton et al, 2000).  
Results released in 1999 revealed similar benefits for the Type 2 diabetic population, with 
tighter glucose control resulting in a 25% reduction in micro vascular complications 
(95% CI) although reductions in myocardial infarction did not reach significance 
(Stratton et al, 2000).  Risk of hypoglycaemia in those on a combination of insulin and 
sulphonylurea therapy showed a 5.6% increase as well as increased weight gain, although 
the p-values were not reported for this data.  The UKPDS also provided strong evidence 
for the benefits of dietary advice for 3 months following diagnoses prior to initiating 
medication, demonstrating a significant reduction in fasting plasma glucose by 
2.9mmol/l, HbA1c 1.9% and body weight by 3.7kg.  Following publication of these key 
trials many medical centres started using a team approach to treating diabetes, consisting 
of doctors, specialist nurses and dietitians, and clinical targets changed, now aiming for 
progressively tighter glycaemic control.  Diabetes UK recommended treatment which 
currently aims for the following: 
• Blood pressure levels of 130/80 mm Hg or below  
• HbA1c levels of 6.5 per cent  
or below  
• Fasting blood glucose levels of 4-7 mmol/litre  
• Aim for blood glucose levels before meals between 4 and 7mmol/litre 
In light of the findings of the DCCT & UKPDS and the potential effects of intensive 
therapy increasing risk of hypoglycaemia, it is important to know that interventions 
teaching carbohydrate counting and insulin dose adjustment do so safely without 
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increasing episodes of hypoglycaemia.  The DTTP (Diabetes Treatment & Teaching 
Programme), a prospective implementation study carried out across 96 diabetes centres in 
Germany sought to test the effects of such an educational programme on frequency and 
severity of hypoglycaemia.  A total of 9,583 routine care patients were examined before 
and 1 year after the group education and the results clearly indicated that the programme 
provided benefits for patients at previous high risk of severe hypoglycaemia and severe 
ketoacidosis (Samaan et al, 2006).  Regression to the mean was an important bias for the  
study which was not controlled.  However, statistical simulations of baseline results were 
also carried out and demonstrated a reduction in hypoglycaemic events from 6.1 to 4.7 
per patient which was still significant (Pennant et al, 2007).  A further factor which may 
have affected bias was the sub-group analysis which was performed on those with two or 
more episodes of severe ketoacidosis and which due to a reduced sample size, should be 
interpreted with caution.  However, these findings coupled with the positive outcomes of 
the DAFNE trial have resulted in a plethora of DAFNE style course springing up 
throughout the UK.  The DAFNE study (2002) previously mentioned, importantly found 
that the carbohydrate counting intervention resulted in no differences in frequency of 
hypoglycaemia, which demonstrates safe reduction of blood glucose levels without 
exacerbation of hypoglycaemia. 
2.5 Carbohydrate counting and insulin dose adjustment and effects on glycaemic control 
(HbA1c) 
Carbohydrate counting is now synonymous with management of Type 1 diabetes 
(National Institute for Health and Clinical Excellence 2003) and the DAFNE (Dose 
Adjustment for Normal Eating with diabetes) programme was a forerunner of many such 
programmes established nationally and internationally, teaching carbohydrate counting 
and insulin dose adjustment for the purpose of gaining clinical and quality of life 
benefits.   The evidence base for the DAFNE programme was published in 2002, with 
results from the UK based randomised controlled trial which involved two randomised 
groups of adults with Type 1 diabetes with moderate or poor glycaemic control defined as 
HbA1c 7.5–12%.  The study measured HBA1c, frequency of hypoglycaemia, quality of 
life and effects on weight.  Half entered the programme immediately and half delayed 
entering the programme for six months whilst still receiving their normal diabetes care.  
When the groups were compared at 6 months, the mean difference for HBA1c between 
groups was 1.0%, P<0.0001.  At twelve months the difference in HBA1c had reduced to 
0.5%, P<0.001 but was nevertheless significant with one quarter of those in the early 
intervention arm sustaining an HBA1c of 1.5% below their original value.  Although the 
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results were encouraging it should be remembered that many factors influence glycaemic 
control and it is therefore difficult to attribute the change to any one factor alone. For 
example it is possible that the beneficial effect was simply related to an increased 
frequency of insulin injections in patients using this approach.  Furthermore poor 
compliance with diet and/or diabetes medications are well recognized to be major 
contributing factors to poor diabetes control.  Given that the high baseline HbA1c was 9.4 
% which indicates irregular compliance, it may not be unreasonable to expect an 
improvement in the setting of a research trial particularly where this involved extensive 
diabetic education.   
As demonstrated, tight glycaemic control therefore is paramount to modern diabetes care 
and it is pertinent that our study should assess the effect of our intervention on HbA1c 
which is the gold standard measure.  However, it must be pointed out that whilst no-one 
will argue with the effects of self-management education upon glycaemic control, the 
evidence to show a sustained effect upon HbA1c is mixed.  This was demonstrated in a 
meta-analysis by Norris et al (2002) assessing the effects of 31 RCTs which found that on 
average the intervention decreased glucose levels by 0.76% at immediate follow up, by 
0.26% at 1-3 months follow up, and by 0.26% at 4 months follow up.  However, it is 
known that RCT’s are not always thought to be feasible in community based education 
interventions as they emphasis efficacy to the exclusion of other factors influencing 
effectiveness, which could in turn have influenced the results (Norris et al, 2002). 
 
The original DAFNE trial did indeed demonstrate a 1% reduction in HbA1c at the 6 
month baseline, although at one year this benefit had dropped to 0.5% indicating a 
reduced level of benefit over time.  Follow up at 2 years indicated maintenance of the 
0.5% benefit and further follow up published in Diabetic Medicine in 2007 by DAFNE 
(Speight et al, 2007), reported that re-testing the original feasibility study cohort 
demonstrated a mean improvement in HbA1c of 0.36% at 44 months post course.  This is 
encouraging in that whilst some benefit is lost, there appear to be lasting benefits in 
HbA1c and therefore subsequent long term diabetes complications.  Similar results are 
reported by other regional programmes across the UK which report reductions of 0.5% in 
HbA1c at 6 months.  A programme called BBC (Basal Bolus Conversion Groups: 
Delivery of structured patient education) run by the Queen Alexandra Hospital, 
Portsmouth, using a sample size of 67 patients, detected a mean reduction of 0.6% in 
HbA1c at 3 months. A similar result was found by the CIGS (Carbohydrate and Insulin 
Structured Group Education Sessions) programme run by the Queen Alexandra Hospital 
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in Portsmouth.  They used a sample size of 26 and recorded a 0.5% reduction in HbA1c 
at 3 and 6 months (Griffiths & Turner, 2008).  However, the regional studies have not 
followed up patients beyond 6 months, and DAFNE remains the only study to evaluate 
long term results of these programmes upon HbA1c.  Whilst HbA1c is the gold standard 
measurement of glycaemic control and is clinically very significant, clinical observation  
demonstrates that reducing glycaemic excursions, which may not always influence 
HbA1c, often results in improved patient wellbeing, reduced incidence of hypoglycaemia 
and correspondingly improved quality of life.  Therefore, while HbA1c improvements are 
and should be our main clinical goal, where this is not achieved, it should not be assumed 
that no benefit to glycaemic control has occurred.  However, HbA1c is monitored in all 
patients with diabetes to assess levels of overall control and it is known that three month 
follow is appropriate as a necessary time lapse for an accurate reflection of change in 
HbA1c.  DCCT data showed that the most recent 30 days glycaemia contributes 50% to 
HbA1c and the previous 3-4 months contributes 10%.  A time measure of greater than 
eight weeks is therefore considered necessary for HbA1c to accurately reflect changes in 
glycaemic control (DCCT, 1993).  This service evaluation aims to measure the effects of 
the 4-Step programme on HbA1c at four months follow up. 
 
2.6 Carbohydrate counting and insulin dose adjustment and hypoglycaemia awareness  
Hypoglycaemia unawareness is defined as the onset of neuroglycopenia before the 
appearance of autonomic warning symptoms (De Galan et al, 2006).  Neuroglycopenia 
occurs when the brain becomes glucose deprived and function is impaired.  In the normal 
course of events, patients will detect and treat hypoglycaemia before neuroglycopenia 
occurs and the inability to detect and treat hypo symptoms in good time can be 
dangerous, leading to severe hypoglycaemia with potentially fatal outcomes (De Galan et 
al, 2006).  Glucose counter regulation in patients with Type 1 diabetes is typically 
impaired with the loss of insulin capacity disrupting the first line defence against falling 
glucose levels, which in turn results in inadequate glucagon response. There is then a 
resulting lowering of the glycaemic threshold for these responses to lower levels of 
glycaemia (Meneilly et al, 1994) meaning patient awareness of the hypoglycaemic event 
will be impaired to some extent.  Any episode of hypoglycaemia can provoke this 
problem resulting in a cycle of worsening counter regulation and eventually to 
hypoglycaemic unawareness.    
 
It is known that “the most effective way of reducing risk of hypoglycaemia unawareness 
is to reduce risk of hypoglycaemia” (Fanelli et al, 1993) and therefore this must be the 
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goal of treatment whilst at the same time aiming for optimal glycaemic control 
(MacLeod, 2000).  Clinical concerns may result in a reluctance to optimise insulin 
therapy, for fear of inducing hypoglycaemia (Hayes, M., 2008), which could adversely  
 
affect long term outcomes for people with diabetes.  Blood glucose monitoring, 
individualised targets and educational programmes are important in a bid to prevent and 
manage this problem and many training courses delivered with the aim of achieving tight 
blood glucose control are measuring the effects of the training upon hypoglycaemic 
awareness.  
 
DAFNE style training is associated with significant improvement in HbA1c, reduction in 
severe hypoglycaemia and improvements in self-reported hypoglycaemia awareness 
(Samaan et al, 2006).  The study assessed retrospective data on 9583 patients who had 
attended the courses over a 12 year period by way of sub-group analysis.  Before 
attending the training, mean incidence of severe hypoglycaemia was 6.1 ± 9.6 events per 
patient per year and following training this was reduced to 1.4 ± 5.4 events.  Before the 
training all participants of the subgroup had at least three episodes, 26% had ≥ six 
episodes and 8% had ≥ episodes of severe  hypoglycaemia.  After the training, 56% of 
patients had none, 20% had two, and 15% had three or more episodes.  The adjusted 
mean differences of severe hypoglycaemia before and after the interventions was - 4.7 
events per patient per year with a (p<0.000), a significant overall reduction which would 
be expected to impact favourably upon awareness (Samaan et al, 2006).  This study will 
seek to assess the impact of the 4-Step programme upon hypoglycaemia awareness.  
 
2.7 Carbohydrate counting and insulin dose adjustment and Weight 
Weight maintenance is a pivotal part of diabetes management, with weight gain leading 
to increasing insulin resistance, increased insulin requirements and a consequent 
downward spiral of worsening control. Weight gain is a well-known side effect of insulin 
therapy and previous studies demonstrate weight increases of  up to 21% in one year with 
some insulin regimes (Davies & Wylie-Rosett, 2008). It is important that education 
models which offer food freedom are not shown to lead to weight gain which could in 
turn worsen glycaemic control. There are a number of reasons why carbohydrate 
counting courses can impact upon weight and these are summarised in Table 2.1 
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Table 2.1: Reasons why people with Type 1 Diabetes who enjoy greater dietary freedom may gain or 
lose weight 
Gain weight Lose weight 
• Eating more or larger food servings 
• Eating food higher in calories than 
normal ie chocolate or cakes 
• Forgetting about healthy eating 
principles – concentrating on 
carbohydrates only 
• Efficient glucose storing with better 
insulin match 
• Higher total dose of insulin 
• Less total insulin 
• Fewer snacks 
• Skipping meals or eating smaller 
portions 
• Eating to hunger rather than to treat 
hypoglycaemic events 
• Treat hypoglycaemic events 
appropriately 
• Feel well therefore do more exercise 
   Table 2.1: Reasons why people with type 1 diabetes who enjoy greater dietary freedom may gain 
    or lose weight (Emma Jenkins, 2006) 
 
There is limited published research available assessing the effects of these courses upon 
weight/BMI.  As previously reported the original DAFNE trial was reported as showing 
‘a fall of 1% in HbA1c and quality of life, without increasing hypoglycaemia or mean 
weight gain.  A study published in 2008 evaluated two strategies for determining 
appropriate dosage of mealtime insulin and found weight gain was a problem in both 
groups.  A simple algorithm that adjusted meal time insulin dose based on weekly 
average pre-meal glucose levels was compared with an algorithm based on carbohydrate 
counting as taught in the DAFNE style programmes.  Interestingly, both groups achieved 
equivalent reductions in glycaemic control, although effects upon weight were different.  
Over the course of the 24 week study period both of the groups gained weight with the 
carbohydrate counting group gaining 2.3% compared with a 3.4% difference in the 
algorithm group. The 1% difference did not reach significance over the 6 month period as 
the study was not adequately powered to reach significance (Bergenstal et al, 2008).  
However, this level of weight gain over time could be significant and have an adverse 
effect (Davis & Wylie Rosett, 2008).  In 2008 the Diabetes Education Network which 
was founded in 2003 to support diabetes teams in developing programmes, assessed 
results from 209 patients who had attended courses across seven UK centres and found 
no significant difference in weight from baseline to one year follow up (Everett, 2008).  
Due to the concerns around weight gain in diabetes management, it is now recognised as 
pertinent for local programmes to assess effects of weight alongside HbA1c and quality 
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of life benefits in order to ensure that the programmes do not cause weight gain. This 
study will therefore aim to identify the effects of the ‘4-step’ programme upon body 
weight.  
 
2.8 Carbohydrate counting and insulin dose adjustment and Quality of Life  
Patients with diabetes face many challenges.  These include changes in lifestyle and the 
possibility of developing debilitating and life-threatening complications which can induce 
stress and fear.  Many have to cope with sexual dysfunction and in a study by De 
Berardis et al, (2002), 45.6% of diabetic patients with frequent erectile dysfunction 
reported severe depressive symptoms.  In a cross-sectional case-control study in Canada, 
eating disorders were more prevalent in diabetic subjects (10%) than in non-diabetic 
controls (4%), (p=0.001) (Jones et al, 2000).   According to a number of cross-sectional 
studies Type 1 diabetes is associated with a high prevalence of psychiatric disorders 
(Petrak et al, 2003).  There is also increasing evidence of a link between psychiatric 
disorders and poorly controlled diabetes (Lustman et al, 2000) with patients caught in a 
trap of depression and worsening glycaemic control.  In 2001 a meta-analysis by 
Anderson et al, assessing the prevalence of co-morbid depression in adults with diabetes, 
found that the presence of diabetes in fact doubles the odds of co-morbid depression in 
those studies which contained a control group of non-diabetic subjects (48% of studies).  
The review used odds ratios to assess the rate and likelihood of depression as a function 
of type of diabetes, sex, subject source, depression assessment method and study design.  
In the controlled studies the results did not differ by gender, type of diabetes, subject 
source or assessment method, although in the uncontrolled studies, the prevalence of 
comorbid depression was 28% higher in diabetic women than in diabetic men. Systematic 
reviews are known to be prone to publication bias which can limit generalizability, 
although depression was not the principle focus of many included studies.  However 
some of the studies contained very small sample sizes and some were not population 
based which can influence the stability of the findings.  Although the authors were unable 
to carry out a multivariate analysis controlling for all potential moderators, the odds ratios 
were uniformly similar in the tests suggesting that the two-fold increased likelihood of 
depression associated with diabetes is fairly robust and generalizable (Anderson et al, 
2001).   
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Following the establishment of a link between depression and diabetes, a further 
relationship with glycaemic control was demonstrated in 2000 in a meta-analysis by 
Lustman and colleagues and published in Diabetes Care.  Thirty one studies were divided 
into cross-sectional studies (n+26) and RCT’s (n+5) and due to the RCTs being found to 
be heterogeneous they were not subjected to meta-analysis, leaving the 26 cross-sectional  
studies to be examined.  Depression was found to be significantly associated with 
hyperglycaemia (p<0.001). Although the effect size of 0.17 demonstrates that depression 
accounts for a small amount (3%) of the variance in blood glucose levels, this would be 
of significance in clinical practice.  And as would be expected there was found to be no 
difference between Type 1 and Type 2 populations which showed similar effect sizes.   
In recognition of the strong associations between diabetes and psychiatric co-morbidities, 
personal empowerment of patients is being seen in recent years as increasingly important 
in the treatment of diabetes in terms of improving quality of life.  In the White Paper 
entitled Our Healthier Nation: Choosing Health (Department of Health, 2004) emphasis 
was placed upon the importance of personal choice in achieving good health.  According 
to the National Service Framework for Diabetes: Delivery Strategy (Department of 
Health & Diabetes UK, 2003),  “patient empowerment and a person-centred approach 
should be a key part of successful treatment, as there is much evidence to show that these 
improve both clinical outcomes and quality of life”.  Recommendations include the 
provision of support and structured education alongside medication and clinical care as 
required, of which a main aim is to enable those with diabetes to self-manage their 
lifestyles and their diabetes.  Improving psychosocial outcomes and therefore quality of 
life are now widely accepted as key goals in diabetes and these are linked to patient 
centred education which emphasises patient autonomy and empowerment, shared 
decision making and shared care.  Whereas, as previously discussed, the longer term 
sustained benefits of glycaemic control are in question, the evidence that self-
management education improves quality of life and psychological wellbeing is well 
supported in the literature.  A systematic review published in Psychology, Health & 
Medicine in 2007, described empowerment as ‘helping patients discover and develop the 
inherent capacity to be responsible for one’s own life.  (Debono et al, 2007).  The 
DAFNE (2002) Trial previously discussed, used a Diabetes Treatment Satisfaction 
Questionnaire to assess total treatment satisfaction. The mean difference in questionnaire 
scores between groups at 6 months was 8.75 (p=0.001), with the immediate group 
demonstrating greater satisfaction levels with diabetes treatment.   Similarly, in 2008 the 
Diabetes Education Network mentioned previously, found quality of life scores from the 
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PAID (problem areas in diabetes) questionnaires improved significantly over one year 
from baseline (p<0.001). 
 
Improvements in quality of life for the patient with diabetes are now considered 
paramount in diabetes care and all current studies indicate that carbohydrate counting 
interventions improve service satisfaction levels for the patient, offer a more positive 
diabetes experience for the patient, increase patient confidence and ultimately patient 
empowerment  
 
2.9 Group vs Clinic – comparing educational models 
As previously outlined, the NSF (2003) highlights the necessity to offer structured 
education to all patients with diabetes. The guidance also highlights the need to 
individualise education to meet different learning styles.  Similarly, health professionals 
should identify the need to offer a flexible approach in order that all patients can access 
self-management education.  The ‘4-Step’ programme was designed with this in mind 
and offers patients a choice of individual and group education which are different in their 
approach.  As demonstrated there is much evidence demonstrating that structured 
education among diabetes patients is effective in improving knowledge, blood glucose 
control, and psychological well-being (Department of Health & Diabetes UK, 2005) and 
there is some  evidence to suggest that group education is a more effective format than 
one to one clinics (Norris et al, 2002).  Whilst it is important to continue to offer a variety 
of educational formats, it could be useful to explore levels of effectiveness in both 
methods of delivery, with the aim of improving future service delivery.  
 
In line with clinical audit guidelines, this study will seek to measure the effects of 
Aintree’s 4-Step programme upon HbA1c, Weight, Quality of life and Hypoglycaemia 
Awareness.  It will also assess the effectiveness of both groups and individual clinics. 
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3 Methodology  
 
3.1 Design 
This service evaluation was carried out at Walton Diabetes Centre, at Aintree University 
Hospital Trust in Liverpool, assessing a total of 52 patients attending the four week ‘4-
Step’ education programme for carbohydrate counting & insulin dose adjustment, to 
assess the effectiveness of the programme in terms of HbA1c, Weight, Quality of life and 
Hypoglycaemia awareness levels.  The programme was offered in two formats, being 
group education and one to one joint clinics and patients were enrolled according to their 
convenience and preference.   
 
3.2 Population & Subjects 
The Aintree ‘4-Step’ programme is a rolling programme and the data collection is an on-
going process for monitoring effectiveness.  Criteria for the ‘4-Step’ programme includes 
all male and female adults with Type 1 Diabetes on multiple daily injections of insulin, 
aged 16 and over. Those excluded from data collection include  those undergoing renal 
dialysis or chemotherapy/radiotherapy, those on weight management programmes and 
those receiving nutrition support, due to confounding effects upon weight and glycaemic 
control.   For the service evaluation, data was collected from fifty two patients attending 
the programme over a period of approximately six months and analysed retrospectively.  
Gender and ages of participants are outlined below 
 
Gender Male n=20 
 Female n=32 
Age Mean age 39 (23-61) 
 
Table 3.1 Patient demographics 
 
At visit one all patients were made aware of the on-going data collection for audit 
purposes and were given the opportunity to opt-out if they wished.  In this case HbA1c 
and weight were still recorded as these are a necessary part of routine clinical care, 
although participation in questionnaires was not mandatory.  The programme was four 
weeks duration and patients were followed up three months after completion of the 
programme.  For those participating in data collection all measurements were repeated at 
the follow up visit three months after completion of the programme.  
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3.4 Measurements 
Table 3.2 Measurements 
 
HbA1c is used to assess glycaemic control.  It measures levels of exposure to glucose and 
subsequent protein glycosylation in percentage terms over a period of 8 to 12 weeks. 
(Jeffcoate, 2003).   HbA1c is measured in all patients who attend the diabetes clinic, is 
taken on site according to normal clinic protocol and results are entered by the laboratory 
onto the ‘Medway’ computerised patient information system which is accessible to all 
clinical staff as well as onto the medical case note.  Weight is also recorded at every 
clinic visit and entered into the medical case note.    
 
Two questionnaires were used to assess quality of life and hypoglycaemia awareness.  
The  ‘Problem Areas in Diabetes’ (PAID) questionnaire was used to assess quality of life 
with diabetes (Polonsky et al, 1995) initially and at three months follow up.  Cross 
sectional questionnaires are objective methods used to collect data about people’s 
experience and behaviours (Boynton & Greenhalgh, 2004) and are an accepted technique 
for assessment of healthcare treatments and patient satisfaction (Winocour et al, 2002).  
However, they can be limited by their sensitivity.  For example if a generally high level 
of satisfaction is recorded it can be difficult to distinguish the factors that contribute to 
the satisfaction (Stanga et al, 2003) and in order to accurately assess patient opinion of 
quality of care, it is preferable for validated measures of patient satisfaction to be used.  
Continuous responses rated on a five to seven point Likert scale as found in the PAID 
questionnaire allow for discrimination between levels of satisfaction that cannot be 
achieved with closed questions which have categorical answers.   
 
The Problem Areas in Diabetes (PAID) Scale is a fully validated self-reported measure of 
psychosocial adjustment specific to diabetes. It consists of a twenty item questionnaire 
with scores from 0-4 for each item and a highest possible score of 80 points per 
questionnaire (Appendix 2). High scores indicate more severe problems and the resource 
is used as a measure of diabetes distress (Polonsky et al, 1995).   Patients’ own 
Measurements taken at baseline and repeated after four months 
HbA1c Blood test documented on Medway and in case notes 
Weight Weight documented on Medway and in case notes 
Quality of life Problem Areas in Diabetes (PAID) questionnaire (Appendix 2) 
Hypoglycaemia 
awareness 
Hypoglycaemia Awareness (R-values) questionnaire (Appendix 3) 
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assessment of their diabetes experience is important. Dr. William Polonsky, a researcher 
in diabetes-related stress at the Joslin Diabetes Centre suggested that ‘when assessing 
health-related quality of life, one should consider the patient’s views of his own health 
and wellbeing in the areas of physical, psychological and social functioning’.  A study 
published in 2003 measured the responsiveness (sensitivity to change over time) of the 
PAID tool by extracting data from seven diabetes intervention studies and concluded with 
strong support for its effectiveness (Welch et al, 2003).  The tool was therefore chosen 
due to its comprehensive assessment of all these factors, as well as demonstrating high 
internal reliability and good item-to-total correlations. 
 
The Hypoglycaemia Awareness Scale is a validated questionnaire used to help patients 
identify their levels of awareness using a series of eight questions.  Patients score a series 
of eight questions with either an ‘A’ or ‘R’ response to each (see Appendix 3).  Each 
answer carries an ‘A’ or ‘R’ score with a maximum of seven ‘R’ responses (0-7).  A 
score above four ‘R’ responses indicates ‘reduced hypoglycaemia awareness’ (Clark et al, 
1995).  This tool is one of three methods which have been proposed to assess awareness 
of hypoglycaemia for clinical application. A cohort study sought to test the accuracy of 
the three methods in detecting reduced hypoglycaemia awareness.   Eighty patients 
completed all three questionnaires whilst at the same time carrying out regular blood 
glucose monitoring and the Hypoglycaemia Awareness Scale (Clark et al, 1995) was 
found to have a strong level of accuracy in identifying impaired awareness (p=0.001) and 
was therefore recommended for use in routine clinical care (Geddes et al, 2007). 
 
3.5 Data Management & Analysis 
 
Statistical analysis 
Statistical analysis was carried out using SPSS version 16.0 for windows (SPSS, 
Chicago, Ill., USA).  
 
Descriptive statistics were used to explore the data initially followed by the use of 
appropriate graphs to identify trends or differences. The data is presented as mean, and 
standard deviation. 
 
This was followed by the use of inferential statistics as a series of dependent (repeated) t-
tests assuming the data had met the assumptions of normal distribution.  These were 
reported by the letter ‘t’.  If the data failed to meet this assumption, a non-parametric test, 
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Wilcoxon Signed Ranks test was used and reported by the letter ‘z’. Data was analysed 
for normal distribution using histograms (Appendix 4).  All statistical analysis was 
assessed at the 0.05 level (p=<0.05, CI 95%).   
 
Assessment of Weight and HbA1c in the total population (n=52), revealed a normal or 
‘Gaussian’ distribution, meaning that the distribution of the measures in each group were 
even or ‘normal’ based upon sample size.  Therefore paired sample t-tests were chosen.  
 
Assessment of the ranked data in the Hypoglycaemia Awareness Questionnaires and 
Quality of life (PAID) questionnaires revealed non-normal distribution.  Furthermore 
these represent an ordinal scale of measurement and therefore Wilcoxon Signed Ranks 
test was chosen for correctness.     
 
Comparing groups with clinics required ‘splitting’ the population into smaller samples 
(n=30 and n=22) and histograms revealed skewness in the data (Appendix 4). Wilcoxon 
Signed Ranks test was used to reduce inaccuracy.   
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4 Results 
 
 
4.1 Subject characteristics 
For the service evaluation, data was collected from fifty two patients attending the 
programme over a period of approximately six months and analysed retrospectively (see 
data collection form Appendix 5).   
 
Criteria for the ‘4-Step’ programme included all male and female adults with Type 1 
Diabetes on multiple daily injections of insulin, aged 16 and over.  In order to reduce 
confounding factors patients with certain conditions were excluded from data collection.  
These included, patients receiving nutrition support, those on chemotherapy/radiotherapy, 
those on renal dialysis, those who were pregnant, or those on weight management 
programmes/medications.  
 
Data was collected over a period of six months with all qualifying patients being given 
the option of opting out of data collection.  By the end of six month, a total of fifty two 
patients had enrolled and all agreed to data collection. There were thirty two females and 
twenty males who participated in the programme, with a mean age of thirty nine and an 
age range of twenty six to sixty one.  Thirty patients preferred group sessions and twenty 
two patients preferred clinic sessions. 
 
All fifty two patients completed the programme and attended follow up. This is in part 
due to the high demand for the programme, coupled with the ‘4-Step’ assessment clinic, 
the purpose of which is to explain the commitment required and offer patients a ‘drop-
out’ option if required, prior to commencing the programme.  This results in very low 
levels of non-attendance.  
 
Results are displayed with each outcome measure in the total population, followed by the 
same outcome comparison between groups and clinics.  Histograms can be found in 
Appendix 4, data collections in Appendix 5 and statistical output in Appendix 6.  
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4.2 Results 
The primary aim of this study was to assess the effects of the ‘4-Step’ programme on 
HbA1c, Weight, Quality of Life and Hypoglycaemia awareness before and after the ‘4-
Step’ programme (n=52). The secondary aim was to assess whether differences occurred 
in those undergoing ‘group’ education (n=30) as opposed to those undergoing ‘clinic’ 
education (n=22).   
 
In line with the stated hypothesis, in the total population there were marked 
improvements in the mean values of the patients’ HbA1c and Quality of life scores after 
the ‘4-Step’ programme, and no significant change in weight. However, contrary to 
expected outcomes, there was no improvement in Hypoglycaemia awareness (see Table 
4.1).  Group and clinic data demonstrated that group education was more likely to 
improve psychosocial outcomes such as Quality of life and Weight and clinics were more 
likely to improve clinical outcomes such as HbA1c and Hypoglycaemia awareness. 
 
 
Table 4.1: Mean clinical and psychological outcomes before and after the ‘4-
Step’ programme (presented as mean ± SD) in total population 
 
 
 
 
 
Clinical 
Outcome 
Clinical goal Baseline 
 
After 
Intervention  
 
Change P value 
 
HbA1c (%) 
 
Percentage 
reduction 
 
 
9.33% 
 ± 1.43 
 
 
9.04% 
 ± 1.33 
 
 
0.29% 
 
 
(p=0.008)  
 
 
 
Weight 
(kilograms) 
 
Weight reduction 
or maintenance 
 
77.50 kg 
 ± 2.14 
 
 
77.02 kg  
± 2.09 
 
 
0.5 kg 
 
 
(p=0.100) 
 
 
 
Problem areas in 
diabetes  
(Score 0-80) 
 
 
Reduction in 
score 
 
Score 28 
 ± 18.81 
 
 
Score 19 
 ± 14.62 
 
 
-9 
 
 
(p=0.000) 
 
Hypoglycaemia 
awareness  
(Score 0-7) 
 
 
Reduction in 
score 
 
Score 
1.58  ± 
1.57 
 
 
Score 1.33  
± 1.45 
 
 
0.25 
 
 
(p=0.052) 
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 Figure 4.0  Mean HbA1c (as %) at baseline and following 
 ‘4-Step’ programme in total population 
 
 
 
Positive improvements in HbA1c from baseline to four months follow up were observed 
in the total population (n=52).  Mean HbA1c at baseline was 9.33% ± 1.43 and this 
dropped to 9.04% ± 1.33 following the ‘4-Step’ programme (Figure 4.0).   
 
The ‘4-Step’ programme improved HbA1c levels by 0.29%.  This was statistically 
significant (t=2.749, p=0.008). 
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   Figure 4.1  Mean HbA1c (as %) at baseline and following 
   ‘4-Step’ programme in groups and clinics 
 
 
 
Group: Positive improvements in HbA1c from baseline to four months follow up were 
observed in those undertaking group education (n=30).  Mean HbA1c at baseline was 
9.38% ± 1.52 and this dropped to 9.10% ± 1.45 following the ‘4-Step’ programme 
(Figure 4.1).  
 
The ‘4-Step’ programme improved HbA1c levels by 0.28% in those undergoing group 
education and this was not statistically significant (z=-1.592, p=0.111). 
 
 
 
Clinic: Positive improvements in HbA1c from baseline to four months follow up were 
observed in those undertaking joint clinic education (n=22). Mean HbA1c at baseline was  
± 1.32 and this dropped to 8.97% ± 1.16 following the ‘4-Step’ programme (Figure 4.1).   
 
The ‘4-Step’ programme improved HbA1c levels by 0.31% in those undertaking joint 
clinic education and this was statistically significant (z=-2088, p=0.037). 
 
 
8.97
9.1
9.28
9.38
8.6 8.8 9 9.2 9.4 9.6
Clinic
Group
HbA1c at baseline
HbA1c at follow up
 
 
        
 
 
 
 
 
 
Tota
in th
drop
 
The
sign
 
  
            Figur
  
    Figu
    prog
l mean we
e total pop
ped to 77.0
 ‘4-Step’ p
ificant (t=1
76.4
76.6
76.8
77
77.2
77.4
77.6
77.8
e 4.2  Numb
re 4.3  Mea
ramme in t
ight loss of
ulation (n=
2 kg  ± 2.0
rogramme
.676, p=0.1
2
Before
Weight ch
ers of patient
n weight (
otal popul
  0.49 kg fr
52).  Mea
9 following
 resulted i
00). 
8
13
Perc
77.51
 '4‐Step' prog
Am
anges in to
 
 
s who lost, m
kg) at base
ation (n=5
om baselin
n weight a
 the ‘4-Ste
n 0.49 kg 
 
 
58
entage weigh
ramme
ount of we
tal populat
aintained an
line and fo
2) 
e to four m
t baseline w
p’ program
weight los
t changes
After '4‐S
ight lost 
ion 
d gained wei
llowing ‘4-
onths follow
as 77.51 k
me. 
s. This wa
Patients who
weight
Patients who
weight
No Change
77.02
tep' program
 
ght (n=52) 
 
Step’  
 up was o
g ± 2.14 a
s not stat
 lost
 gained
me
Results 
bserved 
nd this 
istically 
       
      
        
 
 
        
 
 
 
                  
               
                Fig
                Fig
  Figure
  progr
Clini
Grou
W
                  
ure 4.4  Wei
ure 4.5  Wei
 4.6  Mean
amme in  g
11
74.6
76.8
74.7
79.5
70
c
p
eight cha
                  
ght changes i
ght changes i
 Weight (k
roups and
45.1
Group 
.9
Clinic w
75
 
nges in gro
   
n those atten
n those atten
g) at basel
 clinics 
11.8
weight cha
eight cha
80
ups and cl
ding groups
ding clinics
ine and fo
nges in kg
10.5
nges in kg
85
inics 
llowing ‘4-
Ga
Los
Ga
Los
Weight at b
Weight at fo
 
 
 
Step’  
ined
t
ined
t
aseline
llow up
Results 
Results 
 
Weight changes in groups and clinics 
 
 
Group Weight reduction was observed from baseline to four months follow up in those 
undertaking group education (n=30).  Mean weight at baseline was 79.5 kg  ± 13.02 and 
this dropped to 76.8 kg  ± 12.80 following the ‘4-Step’ programme (Figure 4.6). 
 
The ‘4-Step’ programme did result in weight loss in those undergoing group education 
and this was statistically significant (z=--2.012, p=0.043). 
 
 
 
Clinic Weight reduction was not observed from baseline to four months follow up in 
those undertaking clinic education (n=22).  Mean weight at baseline was 74.7 kg ± 12.34 
and this dropped to 74.6 kg ± 12.30 following the ‘4-Step’ programme (Figure 4.6).   
 
The ‘4-Step’ programme resulted in weight reduction in those undertaking joint clinic 
education and this was not statistically significant (z=-.776, p=0.438). 
Discussion 
Quality of Life in total population 
 
 
  Figure 4.7  Mean Quality of life scores at baseline and following ‘4-Step’ 
  programme in total population 
 
 
 
Positive improvements in Quality of Life from baseline to four months follow up were 
observed in the total population (n=52).  Mean problems areas in diabetes (PAID) score 
at baseline was 28 ± 18.81 and this dropped to 19  ± 14.62  following the ‘4-Step’ 
programme (Figure 4.7).   
 
The ‘4-Step’ programme improved problem areas in diabetes (PAID) scores by 9 points.  
This was statistically significant (z=-5.177, p=0.000). 
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  Figure 4.8  Mean Quality of Life scores at baseline and following the  
  ‘4-Step’ programme in groups and clinics 
 
 
 
Group: Positive improvements in  Quality of Life from baseline to four months follow 
up were observed in those undertaking group education  (n=30).  Mean problem areas in 
diabetes (PAID) scores at baseline was 32 ± 17.53 and this dropped to 23 ± 13.53 
following the ‘4-Step’ programme (Figure 4.8).  
 
The ‘4-Step’ programme improved Quality of Life in those undergoing group education 
and this was statistically significant (z=-4003, p=0.000). 
 
 
 
Clinic: Positive improvements in Quality of Life from baseline to four months follow up 
were observed in those undertaking joint clinic education (n=22).  Mean problem areas in 
diabetes (PAID) score at baseline was 23 ± 18.90 and this dropped to 14 ± 15.12 
following the ‘4-Step’ programme (Figure 4.8).   
 
The ‘4-Step’ programme improved Quality of Life in those undertaking joint clinic 
education and this was statistically significant (z=-3.201, p=0.001). 
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              Figure 4.9  Mean Hypoglycaemia Awareness score at baseline and  
  following ‘4-Step’ programme in total population 
 
 
Hypoglycaemia awareness scores dropped by 0.25 points from baseline to four months 
follow up in the total population (n=52).  Mean score at baseline was 1.58 ± 1.57 and this 
dropped to 1.33 ± 1.45 following the ‘4-Step’ programme (Figure 4.9). 
 
The ‘4-Step’ programme resulted in a reduction in hypoglycaemia awareness scores of 
0.25 points and this was not statistically significant (z=-1.945, p=0.052). 
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Hypoglycaemia Awareness in groups and clinics 
 
 
Group Positive improvements were observed in Hypoglycaemia awareness scores from 
baseline to four months follow up in those undertaking group education  (n=30).  Mean 
score at baseline was 1.67 ± 1.68 and this dropped to 1.53 ± 1.71 following the ‘4-Step’ 
programme (Figure 4.10).  
 
The ‘4-Step’ programme did improve Hypoglycaemia awareness in those undergoing 
group education although the result was not statistically significant (z=--0.825, p=0.409). 
 
 
Clinic: Positive improvements Hypoglycaemia awareness scores from baseline to four 
months follow up were observed in those undertaking joint clinic education (n=22).  
Mean score at baseline was 1.45 ± 1.45 and this dropped to 1.04 ± 0.95 following the ‘4-
Step’ programme (Figure 4.10).   
 
The ‘4-Step’ programme improved Hypoglycaemia awareness in those undertaking joint 
clinic education and this was statistically significant (z=-1.998, p=0.046). 
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Discussion 
5.1 Overview  
Aintree Hospital’s ‘4-Step’ programme was developed to offer patients with Type 1 
Diabetes structured patient education by training in carbohydrate counting and insulin 
dose adjustment. The aims of the programme include improving HbA1c, Quality of life 
and Hypoglycaemia awareness, without causing weight gain. 
 
Data was collected from fifty two patients attending the programme over a period of 
approximately six months and analysed retrospectively.  Those excluded from data 
collection included patients undertaking weight reducing programmes, those on 
chemo/radiotherapy, those undergoing renal dialysis and patients receiving nutrition 
support, due to the potential confounding influence upon weight gain and glycaemic 
control.  
 
The programme was offered in two formats and following attendance at the assessment 
clinic, patients were offered a choice of either group education or individual clinics with 
each programme offering the same education in a different method of delivery.  Initial 
data collection was carried out just prior to patients commencing the four week 
programme and repeated three months after completion of the programme, with a total of 
four months between measurements.  
 
In line with National Service Framework recommendations (2003) that structured 
education programmes should be audited to assess for  effectiveness and enable quality 
control, this study tested the effects of the ‘4-Step’ programme in HbA1c, Weight, 
Quality of Life, and Hypoglycaemia awareness in the total sample of 52 patients.  The 
study also looked for outcome differences in terms of group education and individual 
education in samples of 30 and 22 patients respectively.  
 
5.2 Summary of major findings 
The study demonstrated that in line with NSF Guideline (2003) Aintree Hospital’s ‘4-
Step’ programme delivers real benefits to patients with Diabetes in terms of clinical and 
non-clinical outcomes and is an effective structured education tool.  When comparing 
results in the total population (n=52), in line with our stated hypothesis, the study 
revealed that the ‘4 step’ programme could significantly lower HbA1c levels (p=0.008) 
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and improve Quality of life (p=0.000), without increasing weight gain (p=0.100).  
However, contrary to our hypothesis, Hypoglycaemia awareness (p=0.052) did not  
 
improve as a result of the programme (p=0.052).  Interestingly, when comparing results 
in groups and individual clinics, patients in clinics were found to significantly improve 
HbA1c (p=0.037) and Hypoglycaemia awareness (p=0.046), although this was not 
reflected amongst patients in group sessions. Quality of life improved significantly in 
both groups (p=0.000) and clinics (p=0.001) and weight gain only benefitted those 
undergoing group education (p=0.043).  The only aspect to change in both groups and 
clinics was Quality of life with equally significant improvements in both. 
 
5.3 Discussion 
HbA1c  
The study demonstrated an overall reduction of 0.29% in HbA1c (p=0.008) which is in 
line with previously mentioned regional programmes (Griffiths & Turner, 2008) and our 
expected outcome that HbA1c would improve following the programme.  The  previously 
mentioned meta-analysis by Norris et al (2002) showed that average decrease in HbA1c 
one to three months after intervention was a similar 0.26%.  This is in contrast with the 
UK based randomised controlled trial (DAFNE Study Group, 2002) which showed that 
patients enrolled in the DAFNE programme decreased their HbA1c values by 1% six 
months after the intervention (p=0.001,). However, at twelve months follow up this 
benefit had reduced to 0.5% (p=0.001).  The duration of the ‘4-Step’ programme against 
the DAFNE programme may in part explain the lower percentage decrease in HbA1c 
values in our study.  The ‘4-Step’ programme is taught over 3.5 to 12 hours depending 
upon group or individual format and the DAFNE programme is taught as a full time five 
day programme, teaching over 35 to 40 hours. This study demonstrates that significant 
changes can occur in a less cost intensive ‘DAFNE equivalent’ programme of shorter 
duration.  However, the greater HbA1c reduction achieved by the DAFNE programme 
could be due to its more intensive structure and duration.  
 
High baseline HbA1c values are not unusual in acute diabetes settings. Although they can 
highlight irregular compliance with diet and insulin this is by no means always the case.  
Patients can have varying levels of insulin resistance which will influence their response 
to carbohydrate counting. In this study, differences in HbA1c values may have been 
influenced by patients’ individual approaches to carbohydrate counting education. Whilst 
many patients are conscientious, weighing and measuring food with great care, others 
preferred to ‘guess’ carbohydrate values. Some are careful to utilise additional injections 
Discussion 
of insulin for larger snacks while others refuse additional injections.  Whilst it is beyond 
the remit of this study to control or measure patient carbohydrate practices, this could of 
course influence results. It is important to mention that although the result in HbA1c % 
may seem small, even minor improvements in HbA1c after implementation of an 
intervention programme are considered by medical teams to be clinically significant 
(Young et al, 2007 & Pibernik-Okanovic et al, 2009).  Indeed, studies have shown that 
even with minimal decreases in HbA1c values, patients report increased well-being and 
important psychological benefits (Nutbeam et al, 2000 & Bernheimer et al, 2002) and the 
DCCT (1993) linked small changes in HbA1c to long term microvascular and 
macrovascular benefits as well as improved psychological benefits. The medical team at 
Aintree Diabetes Centre fully understand the importance of structured education in 
empowering patients and helping them take control of their condition.   
 
HbA1c – Group and Individual comparisons 
When comparing HbA1c outcomes among patients undergoing groups and clinics, it is 
interesting that HbA1c did not significantly improve in those in groups (p=0.111) 
although there was an improvement in those in individual clinics (p=0.037), which 
contradicts Norris’s suggestions that groups are more effective than clinics in terms of 
outcomes (Norris et al, 2002).   The finding appears to suggest that an individual 
approach to education may result in improved understanding and/or better practices when 
compared to the group sessions.  Whereas group education allows more social interaction 
and ‘practice’ using real foods, clinical observation shows that individual education as 
offered in joint clinics allows a more tailored approach, especially in facilitating patients’ 
understanding of some of the more complex aspects of carbohydrate counting.  The 
difference in HbA1c, although significant, was minimal and the finding does not negate 
the need for group education which may offer other benefits as well as satisfying the need 
for patient choice.  However, the result may highlight difficulties for patients in a group 
situation in fully understanding the complexities of carbohydrate counting and insulin 
adjusting.  
 
Weight  
As stated, one of the aims of diabetes management is maintaining weight within an 
appropriate range. Recent studies have highlighted that one of the challenges of insulin 
regimens is weight gain (Bergenstal et al, 2008 & Davies & Wylie-Rosett, 2008).  Due to 
the nature of the ‘4-Step’ intervention, which allows greater food freedom, weight can be 
expected to increase or decrease depending upon a number of factors. One factor which 
Jenkins (2006) identifies as being contributory to patient’s gaining weight was the 
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tendency to have larger food servings due to now having the ability to adjust insulin dose 
accordingly.  Similarly, more  high calorie snacks could be included as long as these are  
covered with additional insulin. She also pointed out that these patients concentrate on 
carbohydrates only and would forget healthy eating principles. Similarly, patients might 
also develop better glucose storing coupled with a better insulin match.  Correspondingly, 
patients may lose weight due to the process of keeping food diaries and developing 
greater awareness of their diet.  Patients who lose weight, according to Jenkins (2006) are 
those who have practised the knowledge they gained during the structured education 
programme. For instance, these patients now practise eating smaller portions of food or 
they begin to skip meals. They have also learned to appropriately treat hypoglycaemic 
events, use less total insulin and psychologically feel well (Jenkins, 2006). 
 
Whilst weight loss would be desirable, the goal of this study was to ensure that teaching a 
programme which involves greater food freedom should not result in significant weight 
gain.  Results were encouraging, with no significant change in weight at four months 
follow up (p=0.100) for the total group. This was in line with the finding of the Diabetes 
Education Network at one year follow up (Everett, 2008) which reported no weight 
change, and in line with our hypothesis that the programme would not lead to weight 
gain.  However, whilst it could be assumed that there was no overall weight loss benefit, 
closer scrutiny of the data showed that the mean weight of patients before the ‘4 step’ 
programme was 77.5 kg, which decreased to 77.02 kg three months after intervention 
resulting in a 0.48kg overall weight loss. In this study, fifty eight per cent of the 
population lost an average of 1.74 kg while twenty eight per cent gained an average of 
1kg and thirteen per cent reported no weight change. Total weight lost was 52.3 kg and 
total weight gained was 28.0 kg and whilst the results failed to reach significance, it may 
be clinically significant and is reassuring that the trend is for weight loss rather than gain. 
It must be remembered that to patients any positive changes are beneficial, even if small. 
As stressed by Anderson et al (2010), “...the more goals patients attained, the more likely 
they were to improve or maintain their level of glycaemic control”. Furthermore, weight 
is known to effect insulin resistance and even small amounts of weight loss are thought to 
improve glycaemic control.  However, caution is needed in interpreting these results 
which differ from the study by Bergenstal et al (2008) which showed that over a twenty 
four week study period, all participants carbohydrate counting and insulin dose adjusting 
gained 2.4 kg compared to their baseline weights.  Twenty four weeks is perhaps a more 
realistic time frame for weight loss changes and our short intervention may not reflect  
long term changes accurately.   
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Weight – Group and Individual comparisons 
There was no significant difference in baseline weights and follow up weights for 
patients enrolled in individual sessions. However, patients in group sessions showed 
significant weight loss (p=0.043) after the intervention. It is difficult to explain why 
patients in group education sessions may have lost more weight than those in individual 
sessions.  It may be due to the motivational qualities of a small group, where it is 
observed that people discuss diet, lifestyle and fitness regimes.  Another explanation may 
be that unlike in clinic settings, patients in groups practice weighing and measuring foods 
which may increase portion awareness.  However, identified study limitations may have 
caused bias and this is discussed further on. 
 
Quality of life 
Improvement in Quality of life was an important finding.  Whilst improvement in HbA1c 
values are important in the clinical setting and are often considered the benchmark in 
determining the effectiveness of an education programme (Dinneen et al, 2009),  it is 
becoming increasingly recognised that improvement in psychological well-being is a 
major health benefit which should also mark effectiveness of a teaching programme, 
standing equally alongside clinical outcomes.  Statistical tests showed that Quality of life 
scores of the patients improved significantly in the total population (p=0.000) in line with 
our stated hypothesis.  This study resulted in a 9 point change (p=0.000) in PAID scores, 
in line with the findings of the Diabetes Education Network where scores improved by 
8.75 points and the DAFNE (2002) trial which also demonstrated significant 
improvements in paid scores (p=0.001). 
 
As previously reported, Lustman et al (2000) linked poorly controlled diabetes to a high 
prevalence of psychiatric disorders.   Further studies support this finding such as 
Anderson et al (2001) who found that the presence of diabetes could double the odds of 
co-morbid depression. While this study did not specifically investigate the levels of 
depression, the decrease in patients’ Quality of life scores by nine points was highly 
significant, demonstrating that the ‘4 step’ programme, even though of short duration, 
could significantly improve the well-being of patients. The positive change in Quality of 
life scores also demonstrates that the ‘4-Step’ programme meets the National Service 
Framework for Diabetes Standard 3 (Department of Health, 2003), a very important 
guideline highlighting the need to increase patient autonomy in managing diabetes and 
thereby improving quality of life.  
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It may be that improvements in quality of life are linked to improvements in HbA1c as 
studies have shown that conservative changes to HbA1c values can result in patients’ 
increased sense of well-being and self-esteem (Pibernik-Okanovic et al, 2009 & Dinneen 
et al, 2009).  Patient feedback leads to the safe assumption that positive changes in 
quality of life can also be attributed to clinicians sharing greater knowledge and 
responsibility with the patient which in turn leads to increased patient autonomy in 
diabetes/lifestyle decisions and a more positive clinical experience.  When evaluating the 
‘4-Step’ programme, comments received include “I feel in control of my diabetes for the 
first time”, “why did no one teach me this years ago?” and “it’s nice to make decision 
about adjusting my own insulin without having to ring the nurse all the time.”   
 
As mentioned previously, patient empowerment is a key goal in structured education 
outcomes and the results of this study suggest very significant improvements in patient 
empowerment and quality of life.  Although it is clear that quality of life changes did 
occur which is a positive outcome of this study, it is difficult to make assumptions about 
the exact causes of the changes.  Whereas the quality of life (PAID) questionnaire was 
assessed based upon a single score (0-80), closer analysis of the responses, which was 
beyond the remit of this study, could a useful way of determining the causes of change 
and thus would be a more useful tool for service development. 
 
Quality of life – Group and Clinic comparison  
Of those patients undergoing group sessions, seventy eight per cent demonstrated an 
improvement in quality of life (p=0.000) with thirteen per cent not showing any 
improvement.  Of patients undergoing clinic education, seventy two per cent experienced 
a significant improvement in quality of life (p= 0.001) while twenty seven per cent did 
not show any improvement.   
 
Both group and clinic sessions demonstrated highly significant changes in quality of life 
perhaps suggesting that the process of learning new skills to improve diabetes control and 
give greater autonomy is not dependent upon a particular learning format. This reinforces 
the belief that both group and individual education formats are useful vehicles for 
improving diabetes quality of life and should continue to be offered in line with 
maximising patient choice.  In terms of effective use of  resources, those attending group 
education average approximately 1.5 hours of clinical time per patient, whilst those 
attending individual sessions average 2.5 hours of clinical time.  Groups are more  
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efficient in terms of use of clinicians’ time and in view of the lack of additional benefits 
for those undergoing group education one could conclude that group education is the way 
forward. However, as previously stated the National Service Framework encourages 
health professionals to offer a wide variety of learning settings and styles which suit 
different learn needs.  
 
Hypoglycaemia Awareness 
On the hypoglycaemia awareness scale, a score of > 4 indicates reduced hypo awareness.  
Baseline hypoglycaemia awareness data of the patients in this study indicated a good 
level of awareness (mean= 1.57) and an expectation of this study had been to demonstrate 
a significant improvement in hypoglycaemia awareness after the ‘4-Step’ programme as 
demonstrated by the Diabetes Education Network and some regional audits (Everett, 
2008).  However, although the scores improved slightly (mean 1.33), statistical tests 
failed to establish a significant improvement (p=0.052) in hypo awareness in the total 
population.    It is notable that patients had relatively high hypoglycaemia awareness 
levels at the start of the intervention. While the improvement was minimal, the results of 
the study might be different if the sampled population had a lower awareness levels at 
baseline. It is unknown whether the sample was representative of the diabetes population 
in general who have long standing Type 1 diabetes as typical values of hypoglycaemia 
awareness are not quantified in the literature.  
 
During the ‘4-Step’ programme patients often report improvements in ‘frequency’ of 
hypoglycaemia as well as often being observed by the educators.  Whilst it could 
reasonably be expected that the hypoglycaemia awareness data would reflect this change, 
indicating improved hypo sensitivity, unless frequency is measured statistically it fails to 
prove a real long term change, remaining instead a clinical observation. It is possible that 
frequency does improve and over time this would impact upon ‘awareness’ although this 
may not be evident during the short duration of the study, with a longer time period being 
needed to properly reflect changes in hypoglycaemia awareness. As previously suggested 
by McLeod (2000), “the best way of improving risk of hypoglycaemia unawareness is to 
improve risk of hypoglycaemia” as each episode of hypoglycaemia could potentially 
result in a lowering of the glycaemic threshold and an inadequate glucose response 
(Meneilly et al, 1994). Reduction in ‘frequency’ of hypoglycaemic events is immediately 
noticeable to the patient as is much valued by them, offering immediate benefits. Whilst 
this study measured hypoglycaemia awareness, many studies suggest frequency is of  
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greater clinical importance to both patients and health care practitioners (George et al, 
2008, Hermanns et al, 2010, Mbaezue et al, 2010) and the DAFNE (2002) trial reported 
data for ‘frequency’ measurement rather than ‘awareness’.  It may therefore be pertinent 
to suggest that future evaluations of the ‘4-Step’ programme especially if short-term, 
should measure frequency of hypoglycaemia rather than hypoglycaemia awareness.  
Furthermore, as with HbA1c data, a longer study period with follow up at three, six or 
twelve months may more accurately reflect changes in hypoglycaemia awareness.  
 
Hypoglycaemia Awareness – Group and Clinic comparisons 
Of patients undergoing group education, results revealed that whilst mean scores 
improved from 1.67 to 1.53 this failed to reach statistical significance (p=0.409).  Twenty 
four per cent of the patients showed an improvement in hypoglycaemia awareness and 
awareness levels deteriorated in nine per cent of patients.  Fifty seven per cent did not 
show any changes. Correspondingly, of those patients attending individual clinics 
hypoglycaemia awareness significantly improved (p=0.046) with thirty six per cent 
showing an improvement in awareness nineteen per cent experiencing reduced levels of 
awareness. Fifty four per cent did not show any changes. 
  
As previously reported, this corresponds with that of differences in HbA1c between 
groups and clinics, with clinics reporting greater improvements in both HbA1c and 
hypoglycaemia awareness.  Whilst there may be a suggestion that these findings are 
linked with the expectation that reductions in HbA1c would improve hypoglycaemia 
awareness, it seems premature to make these assumptions based upon this study.  In order 
to satisfy this hypothesis, a study of longer duration with a larger sample size would be 
more conclusive, factoring in the identified study limitations.   
 
Whilst the findings of this study suggest a discrepancy between group and clinic 
outcomes, with groups demonstrating better non-clinical benefits and clinics 
demonstrating better clinical benefits, assumptions should not be made without the 
benefit of further research.  However, the study highlights factors which may influence 
outcomes according to mode of delivery and these are worth consideration when shaping 
the structure and content of the ‘4-Step’ programme.  
 
5.4 Study limitations 
• A major limitation of this study is the absence of a control group which makes  
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interpretation of the results of the data limited. Future evaluations could focus on 
group and clinic outcomes in more detail, using larger sample sizes in order to 
draw more meaningful interpretation from the data.  
 
• Group and individual sessions were assessed as secondary outcomes due to the 
limitations with the data.  For example, needing to ‘split’ the data resulted in 
smaller sample sizes for comparison. Also the disparity in the numbers of patients 
who enrolled in group sessions from those who had individual sessions also 
limited the choice of statistical tests and the interpretation of the results.  
Differences in course content could also be a factor due to group sessions being 
longer and therefore more detailed.  Furthermore, patients selected whether to 
attend group or clinic education and this could introduce bias. Due to these 
limitations, the group and clinic comparisons were described as secondary 
outcomes.   
 
• Much of the data was skewed and therefore required non-parametric tests.  Non 
parametric tests are known to be less sensitive and therefore may not have detected 
small differences in data analysis.  Therefore, whilst non parametric tests are more 
accurate, they make lack the sensitivity of parametric tests and this could have 
affected overall results.  
 
• The population was biased in favour of women with 32 females and 21 males 
meaning that the data may have been skewed.  Research demonstrates that Type 1 
diabetes in Europe is male dominant with a 3:2 male to female ratio which this 
study population does not accurately reflect.  Data was collected within the 
restraints of limited clinical resources and a tight time limit imposed.  It is hoped 
that future programme evaluations could increase the data collection time and 
recruit men to women on a 3:2 ratio making the sample more representative. This 
may also be useful to examine gender specific data for differences, which may in 
future help health educators to more specifically meet the needs of men and 
women and the issues pertinent to them. 
 
5.5 Implications and applications for professional practice 
• Unless data collection is over a longer period, future data collection should seek 
to measure hypoglycaemia frequency rather than awareness. 
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• In view of the improved clinical outcomes in the clinic setting, it may be 
beneficial to include some ‘one-to-one’ individual time into the group education 
sessions.  
 
• It may be worth including six and twelve month follow up appointments to see if 
benefits are  sustained or lost over time.  This in turn could highlight the need for 
a ‘4-Step’ refresher programme offered to patients at intervals during their 
diabetes journey.  
 
• The programme may present an opportunity for weight management education 
which could include input from weight management dietitians including practical 
advice about portion sizes and meal balance.  
 
• It is hoped that presentation of the findings of this study to the Diabetes Team at 
Aintree may result in increased resources being made available for the ‘4-Step’ 
programme. Currently patients wait approximately 4 months before commencing 
their structured education programme.  Both the specialist nurse and dietitian who 
run the course are each allocated two, half days per week.  It is hoped that by 
demonstrating the effectiveness of the programme, additional resources would 
enable us to expand capacity in order to more effectively meet the demand such 
as: 
 
- Evening courses for people who work 
- Individualised courses according to age or gender.  This could include 
young persons (16-25) sessions as young people have a very low 
attendance rate in general education programmes. An over sixties 
group may be helpful and separate gender groups. 
 
5.5 Ideas for further research 
• When comparing differences in groups and clinics, group education demonstrated 
greater improvements in Weight and Quality of life and joint clinics demonstrated 
greater improvements in HbA1c and Hypo awareness.  Further research could 
focus upon these changes, to explore the reasons for the differences and seek to 
address them in further programmes. 
 
• Longer term follow-up, perhaps at 6, 12 or 18 months may be helpful in terms of 
identifying whether or not HbA1c benefits are sustained over time.  
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• There is limited research upon the effects of diabetes structured education 
programmes on Weight/BMI. This study shows that this kind of programme has a 
positive effect on more than half of the participants and further research could  
 
include, looking more closely at the reasons why people gain or lose weight 
during the programme.  This information could help shape service provision. 
 
• The Problem Areas in Diabetes (PAID) questionnaire is a ranked series of twenty 
questions which were grouped together for statistical analysis.  Results therefore 
only represented a general ideal on the improvement of the quality of life.  Future 
service evaluations may benefit from splitting the questionnaire into sections with 
questions being grouped according to social relationships, patients perceptions of 
clinical care, and self-care and empowerment. This may lead to better 
interpretation of results and help educators to identify which aspects improved the 
most after the intervention programme.  
 
• Monitoring ‘frequency’ of hypoglycaemia instead of ‘awareness’ may be more 
useful in future service evaluations.  The short study duration may not have been 
sufficient to detect changes in awareness although changes in ‘frequency’ are 
detected much sooner. Hypoglycaemia awareness may be more accurately 
measured in studies of longer duration. 
 
• Emerging evidence is suggesting that in future carbohydrate counting may benefit 
those with Type 2 diabetes and poor diabetes control.  As a Diabetes Centre 
which deals with complex Type 2 patients Aintree is well placed to offer this 
education to people with Type 2 diabetes and compare outcomes with Type 1 
patients.  
 
5.6 Conclusions 
This service evaluation used a combination of clinical tests and questionnaires to 
determine the effects of Aintree University Hospital’s ‘4-Step’ structured education 
programme on HbA1c, Weight, Quality of life and Hypoglycaemia awareness on fifty 
two patients undertaking the programme.  Baseline and follow-up data is automatically 
collected on patients entering the programme for purposes of departmental clinical audit 
unless they fit the exclusion criteria and formed the basis of this study.  The primary 
objectives of the study were to assess baseline and follow up measures in the total 
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population (n=52) and the secondary objectives were to assess differences between 
groups (n=30) and joint clinics (n=22). 
 
The study has served to demonstrate the effectiveness of Aintree’s ‘4-Step’ programme in 
achieving key improvements in clinical and non-clinical aspects of patients’ diabetes 
care. While the improvement in HbA1c is beneficial, it is unclear whether this is 
sustained over time.  Longer term follow-up and refresher education at intervals may 
increase the likelihood of sustained clinical benefits.  Whilst weight loss was shown to be 
minimal, the study importantly demonstrates that the ‘4-Step’ programme does not lead 
to weight gain; a potential factor of programmes enabling greater food freedom. Quality 
of Life improvements were highly significant with impressive improvements. However, 
future studies would benefit from including a more detailed analysis of the Quality of 
Life questionnaire which, whilst highlighting aspects which are most favourably 
influenced by the programme, this would also enable targeting of those aspects which 
demonstrate lower levels of satisfaction for future service provision.  Hypoglycaemia 
Awareness did not improve, possibly due to the short study duration. Future evaluations 
may be better placed to measure frequency of hypoglycaemia for a more accurate 
assessment of the impact of the ‘4-Step’ programme on hypoglycaemic events. 
 
The groups and joint clinics data was interesting, sometimes highlighting important 
changes which were not observed in the overall population.  The study hypothesised that 
group education would demonstrate greater benefits than clinics. However whilst group 
education was found to most positively improve Quality of life and Weight loss, joint 
clinics most positively affected HbA1c and Hypo awareness.  The need to ‘split’ the 
sample for purposes of comparing groups and clinics resulted in smaller sample sizes and 
therefore less accurate results and there were other limiting factors. However, the group 
and clinic comparisons provided interesting insight which could help shape future service 
provision and provide opportunities for further research.  
 
It is important to evaluate health education interventions to ensure effectiveness in terms 
of expected patient benefits as well as inform service changes to increase efficiency and 
cost effectiveness.  This study, whilst demonstrating that the ‘4-Step’ programme delivers 
clinical and psycho-social benefits to patients, also provides invaluable insights which it 
is hoped can inform and stimulate more effective service provision to patients with Type 
1 diabetes undertaking Aintree Hospital’s ‘4-Step’ programme. 
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